Classer les publications sur l'année

  • SantĂ© publique

    Public health impact of human papillomavirus vaccination on prevention of cervical cancer in France

    EL HASNAOUI A, DEMARTEAU N, GRANADOS D, STANDAERT B, DETOURNAY B

    Int J Public Health ; 2012;57(1):149-58

  • Pharmaco-EpidĂ©miologie

    Projection de l’incidence du cancer du sein en 2018 en France

    BOUEE S, GROSCLAUDE P, ALFONSI A, FLORENTIN V, CLAVEL-CHAPELON F, FAGNANI F

    Bulletin du Cancer ; 2010;97(3):293-299

  • Économie de la santĂ©

    Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study

    ARMOIRY X, FAGNANI F, BENBOUBKER L, FACON T, FERMAND JP, HULIN C, MOREAU P, AULAGNER G

    J Clin Pharm Ther ; 2011;36(1):19-26

  • Économie de la santĂ©

    Cost effectivenessof posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for theFrench healthcare system

    MICHALLET M, GANGNEUX JP, LAFUMA A, HERBRECHT R, RIBAUD P, CAILLOT D, DUPONT B, MOREAU P, BERGER P, O’SULLIVAN AK

    J Med Econ ; 2011;14(1):28-35

  • Pharmaco-EpidĂ©miologie

    Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe study

    SPIELMANN M, LUPORSI E, RAY-COQUARD I, DE BOTTON S, AZRIA D, LASOCKI S, LAFUMA A, MAHI L, DERAY G, BUGAT R
    A, MAHI L, DERAY G, BUGAT R

    Eur J Cancer ; 2012;48(1):101-107